Table 3-2 Pretreatment condition 2.
a. Total | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Temperature ≧38°C | Blood test | Hemodynamics | Infection& | |||||||||||||||||||||
(−) | (+) | WBC | CRP | Alb | Cr | ABI | TBI | SPP | Toe pressure | Local (foot) | Systemic | |||||||||||||
n | Median | n | Median | n | Median | n | Median | n | Median | n | Median | n | Median | n | Median | Uninfected | Skin or subcutaneous tissue (erythema)* | Deep tissue# | SIRS$ | |||||
≦2.0 cm | >2.0 cm | (+) | (−) | |||||||||||||||||||||
Rutherford 4 | 232 | 9 | 230 | 6,725 | 214 | 0.55 | 215 | 3.6 | 229 | 1.08 | 121 | 0.56 | 8 | 0.41 | 86 | 20 | 8 | 51.5 | 217 | 12 | 5 | 7 | 5 | 237 |
Rutherford 5 | 688 | 39 | 710 | 7,300 | 690 | 1.00 | 669 | 3.4 | 712 | 2.28 | 463 | 0.61 | 31 | 0.26 | 432 | 22 | 31 | 36 | 480 | 168 | 50 | 33 | 19 | 709 |
Rutherford 6 | 143 | 27 | 169 | 8,600 | 169 | 4.62 | 161 | 2.9 | 169 | 1.90 | 79 | 0.66 | 3 | 0.18 | 92 | 22.5 | 3 | 27 | 50 | 31 | 36 | 54 | 16 | 154 |
Total | 1,063 | 75 | 1,109 | 7,400 | 1,073 | 1.16 | 1,045 | 3.4 | 1,110 | 1.54 | 663 | 0.61 | 42 | 0.27 | 610 | 22 | 42 | 36 | 747 | 211 | 91 | 94 | 40 | 1,100 |
b. ASO | ||||||||||||||||||||||||
Temperature ≧38°C | Blood test | Hemodynamics | Infection& | |||||||||||||||||||||
(−) | (+) | WBC | CRP | Alb | Cr | ABI | TBI | SPP | Toe pressure | Local (foot) | Systemic | |||||||||||||
n | Median | n | Median | n | Median | n | Median | n | Median | n | Median | n | Median | n | Median | Uninfected | Skin or subcutaneous tissue (erythema)* | Deep tissue# | SIRS$ | |||||
≦2.0 cm | >2.0 cm | (+) | (−) | |||||||||||||||||||||
Rutherford 4 | 227 | 9 | 225 | 6,700 | 209 | 0.54 | 210 | 3.6 | 224 | 1.09 | 119 | 0.55 | 8 | 0.41 | 83 | 20 | 8 | 51.5 | 213 | 11 | 5 | 7 | 5 | 232 |
Rutherford 5 | 673 | 37 | 694 | 7,300 | 675 | 1.00 | 654 | 3.4 | 696 | 2.78 | 452 | 0.61 | 30 | 0.25 | 427 | 22 | 30 | 36 | 467 | 166 | 50 | 30 | 17 | 694 |
Rutherford 6 | 142 | 26 | 167 | 8,550 | 167 | 4.62 | 159 | 2.9 | 167 | 1.94 | 78 | 0.66 | 3 | 0.18 | 91 | 22 | 3 | 27 | 50 | 31 | 34 | 54 | 16 | 152 |
Total | 1,042 | 72 | 1,086 | 7,375 | 1,051 | 1.17 | 1,023 | 3.4 | 1,087 | 1.61 | 649 | 0.60 | 41 | 0.26 | 601 | 22 | 41 | 36 | 730 | 208 | 89 | 91 | 38 | 1,078 |
WBC: white blood cell, CRP: C reactive protein, Alb: albumin, Cr: creatinine, ABI: ankle brachial (pressure) index, TBI: toe brachial (pressure) index, SPP: skin perfusion pressure, SIRS: systemic inflammatory response syndrome & Presence of infection is defined by the presence of at least 2 of the following items: ①Local swelling or induration, ②Erythema >0.5 to ≦2 cm around the ulcer, ③Local tenderness or pain, ④Local warmth, ⑤Purulent discharge (thick, opaque to white, or sanguineous secretion). * Local infection at skin and subcutaneous tissue was classified by the spreading of erythema (≦2.0 cm or >2 cm) around the ulcer/gangrene. # Local infection involving structures deeper than skin and subcutaneous tissues (e.g., abscess, osteomyelitis, septic arthritis, fasciitis). $ The signs of SIRS are manifested by two or more of the following: ①Temperature >38 or <36°C, ②Heart rate >90 beats/min, ③Respiratory rate >20 breaths/min or PaCO2 <32 mmHg, ④White blood cell count >12,000 or <4,000 cu/mm or 10% immature (band) forms.